Riverview Trust Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $139K | Hold |
1,080
| – | – | 0.17% | 72 |
|
|
2026
Q1 | $130K | Hold |
1,080
| – | – | 0.16% | 74 |
|
|
2025
Q4 | $114K | Sell |
1,080
-1,145
| -51% | -$107K | 0.14% | 84 |
|
|
2025
Q3 | $187K | Hold |
2,225
| – | – | 0.23% | 63 |
|
|
2025
Q2 | $176K | Sell |
2,225
-8,431
| -79% | -$670K | 0.22% | 60 |
|
|
2025
Q1 | $956K | Sell |
10,656
-3,989
| -27% | -$372K | 0.94% | 21 |
|
|
2024
Q4 | $1.46M | Buy |
14,645
+7
| +0% | +$722 | 1.32% | 16 |
|
|
2024
Q3 | $1.66M | Buy |
14,638
+48
| +0.3% | +$5.7K | 1.46% | 14 |
|
|
2024
Q2 | $1.81M | Sell |
14,590
-11,700
| -45% | -$1.51M | 1.71% | 10 |
|
|
2024
Q1 | $3.47M | Sell |
26,290
-140
| -0.5% | -$17.3K | 2.67% | 8 |
|
|
2023
Q4 | $2.88M | Sell |
26,430
-195
| -0.7% | -$20.2K | 2.93% | 6 |
|
|
2023
Q3 | $2.74M | Buy |
26,625
+1,145
| +4% | +$123K | 2.43% | 7 |
|
|
2023
Q2 | $2.94M | Sell |
25,480
-1,786
| -7% | -$203K | 2.66% | 7 |
|
|
2023
Q1 | $2.9M | Sell |
27,266
-1,129
| -4% | -$122K | 2.67% | 6 |
|
|
2022
Q4 | $3.15M | Buy |
28,395
+68
| +0.2% | +$6.95K | 2.98% | 6 |
|
|
2022
Q3 | $2.44M | Buy |
28,327
+229
| +0.8% | +$20.4K | 2.36% | 7 |
|
|
2022
Q2 | $2.56M | Buy |
28,098
+1,786
| +7% | +$158K | 2.23% | 7 |
|
|
2022
Q1 | $2.16M | Buy |
26,312
+1,801
| +7% | +$142K | 1.6% | 10 |
|
|
2021
Q4 | $1.88M | Sell |
24,511
-701
| -3% | -$55.8K | 1.1% | 14 |
|
|
2021
Q3 | $1.89M | Sell |
25,212
-833
| -3% | -$63.4K | 2% | 12 |
|
|
2021
Q2 | $2.03M | Sell |
26,045
-1,298
| -5% | -$96.5K | 2.14% | 12 |
|
|
2021
Q1 | $2.01M | Sell |
27,343
-147
| -0.5% | -$10.8K | 2.24% | 10 |
|
|
2020
Q4 | $2.15M | Sell |
27,490
-40
| -0.1% | -$3.06K | 2.37% | 8 |
|
|
2020
Q3 | $2.18M | Sell |
27,530
-5,877
| -18% | -$460K | 2.5% | 10 |
|
|
2020
Q2 | $2.46M | Hold |
33,407
| – | – | 2.39% | 9 |
|
|
2020
Q1 | $2.45M | Sell |
33,407
-4,119
| -11% | -$324K | 2.36% | 10 |
|
|
2019
Q4 | $3.26M | Sell |
37,526
-242
| -0.6% | -$19.9K | 2.19% | 10 |
|
|
2019
Q3 | $3.03M | Sell |
37,768
-51
| -0.1% | -$4.09K | 2.11% | 9 |
|
|
2019
Q2 | $3.03M | Hold |
37,819
| – | – | 2.13% | 9 |
|
|
2019
Q1 | $3M | Buy |
37,819
+35
| +0.1% | +$2.62K | 2.27% | 8 |
|
|
2018
Q4 | $2.75M | Buy |
+37,784
| New | +$2.67M | 2.16% | 8 |
|
Other funds holding MRK
Riverview Trust Company's MRK Position: Q2 2026 in Review
Riverview Trust Company held its Merck (MRK) position steady in Q2 2026 at 1,080 shares worth $139K. The position accounts for 0.17% of the portfolio, ranked #72.
Riverview Trust Company first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.47M in Q1 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Riverview Trust Company held 1,080 shares of Merck worth $139K as of Q2 2026.
- Riverview Trust Company left its Merck share count unchanged in Q2 2026.
- Merck made up 0.17% of Riverview Trust Company's portfolio in Q2 2026, its #72 holding.
- Riverview Trust Company first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Riverview Trust Company's Merck position peaked at $3.47M in Q1 2024.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Riverview Trust Company's 13F filing for Q2 2026, filed 3 Aug 2026.